TRO did inhibit growth of cells by arresting cell cycle at G₁ phase. »
01/18/20

Re-irradiation of recurrent or second primary H&N cancer resulted in promising survival rates. »
04/16/20

TLR4 receptor downregulation enhanced HM-induced apoptosis. »
04/16/20

Targeting of TK1 in malignant cells using monoclonal antibodies may be feasible approach. »
04/16/20

SCN9A rs13017637 was associated with severity and duration of TIPN. »
04/16/20

Patients responding to current treatment showed statistically significant decrease in lesion volume. »
04/16/20

Melanoma genomes reflect decline in cell division during ageing. »
04/14/20

No increase in colorectal cancer among patients carrying BRCA mutation. »
09/19/19

Combination of amrubicin and bevacizumab promising regimen. »
01/13/20

Urinary let-7c significantly up-regulated. »
01/04/20